Michael Gelband’s Inogen INGN Stock Holding History

Michael Gelband’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.54M	Buy	393,803 +63,362	+19%	+$419K	0.02%	735
2026 Q1	$2.04M	Buy	+330,441	New	+$2.04M	0.02%	772
2024 Q4	–	Sell	-37,103	Closed	-$360K	–	1754
2024 Q3	$360K	Buy	+37,103	New	+$389K	﹤0.01%	1301
2024 Q2	–	Sell	-569,743	Closed	-$4.6M	–	1728
2024 Q1	$4.6M	Buy	569,743 +55,078	+11%	+$390K	0.04%	416
2023 Q4	$2.83M	Sell	514,665 -285,342	-36%	-$1.51M	0.02%	477
2023 Q3	$4.18M	Buy	800,007 +653,604	+446%	+$4.65M	0.04%	420
2023 Q2	$1.69M	Buy	146,403 +5,546	+4%	+$65.4K	0.01%	880
2023 Q1	$1.76M	Buy	+140,857	New	+$2.7M	0.01%	934
2022 Q4	–	Sell	-10,700	Closed	-$260K	–	1857
2022 Q3	$260K	Buy	+10,700	New	+$295K	﹤0.01%	1562
2021 Q3	–	Sell	-19,377	Closed	-$1.26M	–	2363
2021 Q2	$1.26M	Buy	+19,377	New	+$1.23M	0.01%	884
2021 Q1	–	Sell	-9,376	Closed	-$419K	–	2334
2020 Q4	$419K	Buy	+9,376	New	+$324K	﹤0.01%	1354
2020 Q3	–	Sell	-14,000	Closed	-$497K	–	1977
2020 Q2	$497K	Buy	+14,000	New	+$590K	0.01%	1090
2020 Q1	–	Sell	-7,265	Closed	-$496K	–	1345
2019 Q4	$496K	Buy	+7,265	New	+$456K	0.01%	859

Other funds holding INGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's INGN Position: Q2 2026 in Review

Michael Gelband increased its Inogen (INGN) stake by 19% in Q2 2026, buying an estimated $419K and bringing the position to 393,803 shares worth $2.54M. The position accounts for 0.02% of the portfolio, ranked #735.

Michael Gelband first reported a position in INGN in Q4 2019 and has held it in 13 quarters since. The position peaked at $4.6M in Q1 2024. 128 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

Michael Gelband held 393,803 shares of Inogen worth $2.54M as of Q2 2026.
Michael Gelband bought 63,362 Inogen shares in Q2 2026, an estimated $419K.
Inogen made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #735 holding.
Michael Gelband first reported a position in Inogen in Q4 2019 and has held it in 13 quarters since.
Michael Gelband's Inogen position peaked at $4.6M in Q1 2024.
128 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.